clofarabine has been researched along with Bone Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allegakoen, DV; Çelik, H; Conn, EJ; Flashner, B; Gelmez, E; Han, J; Harris, BT; Hayran, M; Hour, S; Kayraklıoğlu, N; Manara, MC; Oktay, L; Petro, JR; Sciandra, M; Scotlandi, K; Tiwari, PB; Toretsky, JA; Üren, A | 1 |
1 other study(ies) available for clofarabine and Bone Cancer
Article | Year |
---|---|
Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99.
Topics: 12E7 Antigen; A549 Cells; Animals; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Clofarabine; Female; Humans; MCF-7 Cells; Mice; Mice, SCID; Protein Binding; Sarcoma, Ewing; Signal Transduction; Small Molecule Libraries; Xenograft Model Antitumor Assays | 2018 |